CUSIP No. 89616C201
Item 1. Security and Issuer
This Amended Statement of Beneficial Ownership on Schedule 13D (“Amendment 3”) amends and supplements the Statement of Beneficial Ownership on Schedule 13D filed by Fengate Trident LP, Fengate Trident GP Inc., and Fengate Capital Management Ltd. (collectively, the “Reporting Persons”) on May 8, 2017 (the “Initial Schedule 13D”), the Amended Schedule 13D filed by the Reporting Persons on September 14, 2017 (“Amendment 1”) and the Amended Schedule 13D filed by the Reporting Persons on September 18, 2017 (“Amendment 2”) in connection with the parties and matters referenced therein and herein, with respect to the Common Stock, $.001 par value (the “Common Stock”) of Trident Brands, Inc. (the “Issuer”). This Schedule 13D is being filed as a result of the events described in Item 4 below. Any capitalized terms used and not defined in this Amendment 3 shall have the meanings set forth in the Initial Schedule 13D, Amendment 1 and/or Amendment 2. Only those items that are hereby reported are amended; all other items, including previously filed exhibits, remain unchanged and are incorporated by reference herein.
Item 3. Source and Amount of Funds or Other Consideration
The Common Stock reported in this Amendment 3 includes 2,811,866.44 shares of Common Stock beneficially owned by the Reporting Persons and additional shares of Common Stock that may be issued to the Reporting Persons upon conversion of certain Convertible Notes, as defined below. As of April 12, 2019, the Reporting Persons had acquired from the Issuer Convertible Notes in an aggregate principal amount of $18,504,967 and the total accrued but unpaid interest on such Convertible Notes was $2,328,106. None of the shares of Common Stock or Convertible Notes were acquired on margin, or otherwise using borrowed funds or pursuant to any loan or credit arrangement.
Item 4. Purpose of Transaction
The Common Stock and Convertible Notes have been acquired for investment purposes in the ordinary course of the Reporting Persons’ investment activities, and have not been acquired with any purpose of, or with the effect of, changing or influencing the control of the Issuer, or in connection with or as a participant in any transaction having such purpose or effect. From time to time the Reporting Persons may acquire additional securities of the Issuer, or sell securities of the Issuer. In addition to the transactions reported in the Initial Schedule 13D, Amendment 1 and Amendment 2, the following transactions have occurred:
On May 16, 2018, pursuant to the Convertible Note, as amended and restated on May 8, 2017, attached as Exhibit 99.3 to Amendment 1 and incorporated by reference herein, the Reporting Persons purchased Convertible Notes from the Issuer in the amount of $1,500,000, convertible into 2,500,000 shares of Common Stock. As a result, the reporting persons beneficially owned 22,696,475.44 shares of Common Stock, held in the form of 2,811,866.44 shares of Common Stock and convertible notes which, as of May 16, 2019, were convertible into 19,884,609 shares of Common Stock, constituting 43.5 percent of the class of Common Stock (based on the Issuer’s Form 10Q dated April 19, 2018).
On November 30, 2018 the Issuer and the Reporting Persons entered into a Securities Purchase Amendment Agreement (the “SPAA”) pursuant to which the Issuer agreed to issue to the Reporting Persons additional Convertible Notes (the “Additional Convertible Notes”) of up to $10,000,000, subject to certain terms and conditions, with each portion of the principal amount advanced pursuant to the Additional Convertible Notes bearing interest at the rate of twelve percent (12%) per annum and payable monthly in arrears to the Reporting Persons. Outstanding principal and interest will continue to be secured by the general security agreement dated September 26, 2016, which forms a part of the SPA (as defined in the Initial Schedule 13D). The holder of the Additional Convertible Notes may also elect from time to time to convert all or a portion of the outstanding principal and interest into common shares of the Issuer at a 25% discount to the average closing price of the common shares during the 10 trading days immediately prior to the applicable conversion date. The Additional Convertible Notes will mature on May 31, 2020. (When referred to collectively, the Convertible Notes and Additional Convertible Notes are referred to as Convertible Notes.)
On November 30, 2018, pursuant to the SPAA, the Reporting Persons purchased from the Issuer the first tranche of the Additional Convertible Notes in the amount of $3,400,780, convertible into 11,088,800 shares of Common Stock. As a result, the Reporting Persons beneficially owned 33,785,275.44 shares of Common Stock, held in the form of 2,811,866.44 shares of Common Stock and Convertible Notes which, as of November 30, 2018, were convertible into 30,973,409 shares of Common Stock, constituting 53.4 percent of the class of Common Stock (based on the Issuer’s Form 10Q dated October 22, 2018).
On April 12, 2019, pursuant to the SPAA, the Reporting Persons purchased from the Issuer the second tranche of the Additional Convertible Notes in the amount of $2,804,187, convertible into 12,089,425 shares of Common Stock. As a result, the Reporting Persons beneficially owned 44,968,638.44 shares of Common Stock, held in the form of 2,811,866.44 shares of Common Stock and convertible notes which, as of April 12, 2019, were convertible into 42,156,772 shares of Common Stock, constituting 60.4 percent of the class of Common Stock (based on the Issuer’s Form 10Q dated April 22, 2019).